184 related articles for article (PubMed ID: 33804934)
1. 3D Model Characterization by 2D and 3D Imaging in t(14;18)-Positive B-NHL: Perspectives for In Vitro Drug Screens in Follicular Lymphoma.
Gava F; Faria C; Gravelle P; Valero JG; Dobaño-López C; Morin R; Norlund M; Gomes A; Lagarde JM; Rossi C; Bordenave J; Pieruccioni L; Rouquette J; Matas-Céspedes A; Fournié JJ; Ysebaert L; Laurent C; Pérez-Galán P; Bezombes C
Cancers (Basel); 2021 Mar; 13(7):. PubMed ID: 33804934
[TBL] [Abstract][Full Text] [Related]
2. Anti-tumor activity of obinutuzumab and rituximab in a follicular lymphoma 3D model.
Decaup E; Jean C; Laurent C; Gravelle P; Fruchon S; Capilla F; Marrot A; Al Saati T; Frenois FX; Laurent G; Klein C; Varoqueaux N; Savina A; Fournié JJ; Bezombes C
Blood Cancer J; 2013 Aug; 3(8):e131. PubMed ID: 23933705
[TBL] [Abstract][Full Text] [Related]
3. A novel 3D culture model recapitulates primary FL B-cell features and promotes their survival.
Lamaison C; Latour S; Hélaine N; Le Morvan V; Saint-Vanne J; Mahouche I; Monvoisin C; Dussert C; Andrique L; Deleurme L; Dessauge E; Pangault C; Baulande S; Legoix P; Seffals M; Broca-Brisson L; Alessandri K; Carlotti M; Soubeyran P; Merlio JP; Mourcin F; Nassoy P; Recher G; Tarte K; Bresson-Bepoldin L
Blood Adv; 2021 Dec; 5(23):5372-5386. PubMed ID: 34555842
[TBL] [Abstract][Full Text] [Related]
4. T follicular helper cells: a potential therapeutic target in follicular lymphoma.
Ochando J; Braza MS
Oncotarget; 2017 Dec; 8(67):112116-112131. PubMed ID: 29340116
[TBL] [Abstract][Full Text] [Related]
5. Comparative Analysis of 3D Bladder Tumor Spheroids Obtained by Forced Floating and Hanging Drop Methods for Drug Screening.
Amaral RLF; Miranda M; Marcato PD; Swiech K
Front Physiol; 2017; 8():605. PubMed ID: 28878686
[No Abstract] [Full Text] [Related]
6. MRD Detection in B-Cell Non-Hodgkin Lymphomas Using Ig Gene Rearrangements and Chromosomal Translocations as Targets for Real-Time Quantitative PCR.
Pott C; Brüggemann M; Ritgen M; van der Velden VHJ; van Dongen JJM; Kneba M
Methods Mol Biol; 2019; 1956():199-228. PubMed ID: 30779036
[TBL] [Abstract][Full Text] [Related]
7. High Content Screening Characterization of Head and Neck Squamous Cell Carcinoma Multicellular Tumor Spheroid Cultures Generated in 384-Well Ultra-Low Attachment Plates to Screen for Better Cancer Drug Leads.
Kochanek SJ; Close DA; Johnston PA
Assay Drug Dev Technol; 2019 Jan; 17(1):17-36. PubMed ID: 30592624
[TBL] [Abstract][Full Text] [Related]
8. Boosting γδ T cell-mediated antibody-dependent cellular cytotoxicity by PD-1 blockade in follicular lymphoma.
Rossi C; Gravelle P; Decaup E; Bordenave J; Poupot M; Tosolini M; Franchini DM; Laurent C; Morin R; Lagarde JM; Ysebaert L; Ligat L; Jean C; Savina A; Klein C; Céspedes AM; Perez-Galan P; Fournié JJ; Bezombes C
Oncoimmunology; 2019; 8(3):1554175. PubMed ID: 30723586
[TBL] [Abstract][Full Text] [Related]
9. Transcription factor B-cell-specific activator protein (BSAP) is differentially expressed in B cells and in subsets of B-cell lymphomas.
Krenacs L; Himmelmann AW; Quintanilla-Martinez L; Fest T; Riva A; Wellmann A; Bagdi E; Kehrl JH; Jaffe ES; Raffeld M
Blood; 1998 Aug; 92(4):1308-16. PubMed ID: 9694719
[TBL] [Abstract][Full Text] [Related]
10. Differentiation of Diffuse Large B-cell Lymphoma From Follicular Lymphoma Using Texture Analysis on Conventional MR Images at 3.0 Tesla.
Wu X; Sikiö M; Pertovaara H; Järvenpää R; Eskola H; Dastidar P; Kellokumpu-Lehtinen PL
Acad Radiol; 2016 Jun; 23(6):696-703. PubMed ID: 26976622
[TBL] [Abstract][Full Text] [Related]
11. Non-Hodgkin lymphomas: impact of rituximab on overall survival of patients with diffuse large B-cell and follicular lymphoma.
Jaime-Pérez JC; Gamboa-Alonso CM; Vázquez-Mellado de Larracoechea A; Rodríguez-Martínez M; Gutiérrez-Aguirre CH; Marfil-Rivera LJ; Gómez-Almaguer D
Arch Med Res; 2015 Aug; 46(6):454-61. PubMed ID: 26235285
[TBL] [Abstract][Full Text] [Related]
12. The Generation of Three-Dimensional Head and Neck Cancer Models for Drug Discovery in 384-Well Ultra-Low Attachment Microplates.
Close DA; Camarco DP; Shan F; Kochanek SJ; Johnston PA
Methods Mol Biol; 2018; 1683():355-369. PubMed ID: 29082502
[TBL] [Abstract][Full Text] [Related]
13. The HDAC6-selective inhibitor is effective against non-Hodgkin lymphoma and synergizes with ibrutinib in follicular lymphoma.
Lee DH; Kim GW; Kwon SH
Mol Carcinog; 2019 Jun; 58(6):944-956. PubMed ID: 30693983
[TBL] [Abstract][Full Text] [Related]
14. A Tridimensional Model for NK Cell-Mediated ADCC of Follicular Lymphoma.
Decaup E; Rossi C; Gravelle P; Laurent C; Bordenave J; Tosolini M; Tourette A; Perrial E; Dumontet C; Poupot M; Klein C; Savina A; Fournié JJ; Bezombes C
Front Immunol; 2019; 10():1943. PubMed ID: 31475004
[TBL] [Abstract][Full Text] [Related]
15. Hematopoietic cell transplantation for diffuse large B-cell and follicular lymphoma: Current controversies and advances.
Epperla N; Hamadani M
Hematol Oncol Stem Cell Ther; 2017 Dec; 10(4):277-284. PubMed ID: 28633038
[TBL] [Abstract][Full Text] [Related]
16. The therapeutic use of rituximab in non-Hodgkin's lymphoma.
Marcus R; Hagenbeek A
Eur J Haematol Suppl; 2007 Jan; (67):5-14. PubMed ID: 17206982
[TBL] [Abstract][Full Text] [Related]
17. Morphometrical, Morphological, and Immunocytochemical Characterization of a Tool for Cytotoxicity Research: 3D Cultures of Breast Cell Lines Grown in Ultra-Low Attachment Plates.
Malhão F; Macedo AC; Ramos AA; Rocha E
Toxics; 2022 Jul; 10(8):. PubMed ID: 35893848
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical expression of angiogenic cytokines and their receptors in reactive benign lymph nodes and non-Hodgkin lymphoma.
Ho CL; Sheu LF; Li CY
Ann Diagn Pathol; 2003 Feb; 7(1):1-8. PubMed ID: 12616467
[TBL] [Abstract][Full Text] [Related]
19. The discovery and the development of bendamustine for the treatment of non-Hodgkin lymphoma.
Munakata W; Tobinai K
Expert Opin Drug Discov; 2016 Nov; 11(11):1123-1130. PubMed ID: 27598460
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
